News & Info

RVT

Silver Spring, Md. – April 3, 2018 — Robotic VISION Technologies Inc. (RVT), a leader in the machine vision software industry, is transforming the way car manufacturers operate with the latest version upgrade to the award-winning eVisionFactory (eVF™) technology. RVT’s technology has been operating on mission critical equipment at car manufacturing plants for years, in…

Robotic VISION Technologies Releases New Bundle with Award Winning eVF Vision-Guided Software and ADLINK’s NEON Camera

March 20, 2018

RVT

Silver Spring, Md. – March 20, 2018 — Robotic VISION Technologies Inc. (RVT) announced today that it is bundling its award-winning eVisionFactory (eVF) software platform with ADLINK’S NEON-1020 smart camera. The smart Vision Factory (sVF) bundle will bring an easy-to-use, complete solution to any industrial or collaborative application at a competitive price point. “While eVisionFactory…

Robotic VISION Technologies Secures $10.5M in Funding

March 13, 2018

RVT

Silver Spring, Md. – Mar. 13, 2018 — Robotic VISION Technologies Inc. (RVT), a leader in the machine vision software industry, announced today that it has secured more than $10.5 million in funding. The investment comes from a mix of CEO and Director funding as well as investments from technology funds from Silicon Valley, Northern…

LumiThera Announces Initiation of EUROLIGHT Registry Study to Evaluate Long-term Benefits of Photobiomodulation (PBM) Treatment using the Valeda® Light Delivery System in Patients with Dry Age-Related Macular Degeneration (AMD)

January 18, 2024

LumiThera Announces Initiation of EUROLIGHT Registry Study to Evaluate Long-term Benefits of Photobiomodulation (PBM) Treatment using the Valeda® Light Delivery System in Patients with Dry Age-Related Macular Degeneration (AMD) January 16, 2024 SEATTLE–(BUSINESS WIRE)–LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the initiation of the…

LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data

March 16, 2023

LumiThera Announces Sustained Vision Improvement for 24 months in Dry Age-Related Macular Degeneration Subjects from US LIGHTSITE III Clinical Trial Data March 15, 2023 07:17 AM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the 24-month data from its LIGHTSITE…

LumiThera, Inc. Announces Purchase of MacuLogix Assets

July 27, 2022

LumiThera, Inc. Announces Purchase of MacuLogix Assets SEATTLE, July 26, 2022 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the purchase of MacuLogix assets by its wholly owned subsidiary. MacuLogix, Inc., is the leader in early diagnosis of dry Age-related Macular…

LumiThera Presents US LIGHTSITE III Trial Data Showing Improvement in Vision in Intermediate Dry Age-Related Macular Degeneration

June 23, 2022

LumiThera Presents US LIGHTSITE III Trial Data Showing Improvement in Vision in Intermediate Dry Age-Related Macular Degeneration SEATTLE, June 22, 2022 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced detailed findings in its LIGHTSITE III, multi-center clinical trial in non-neovascular (dry) Age-Related Macular Degeneration…

LumiThera Announces US LIGHTSITE III Clinical Trial Meets Primary Efficacy Endpoint in Improving Vision in Dry Age-Related Macular Degeneration Subjects

March 23, 2022

LumiThera Announces US LIGHTSITE III Clinical Trial Meets Primary Efficacy Endpoint in Improving Vision in Dry Age-Related Macular Degeneration Subjects SEATTLE, March 22, 2022 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced positive findings in its LIGHTSITE III, multi-center clinical trial in…

LumiThera Secures Financing to Support Commercial Activities

March 12, 2022

LumiThera Secures Financing to Support Commercial Activities SEATTLE, March 10, 2022 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the completion of a debt financing with Leste Clearway and Serengeti Asset Management. The combined financing provides $5.5M of capital to support integration,…

LumiThera, Inc. Announces Completion of Diopsys, Inc. Acquisition

March 4, 2022

LumiThera, Inc. Announces Completion of Diopsys, Inc. Acquisition SEATTLE, March 3, 2022 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the completion of its acquisition of Diopsys, Inc., a leader in modern visual electrophysiology medical devices that help eye care professionals analyze…

LumiThera Acquires Diopsys, Provider of Light-Based Theranostic Approach to Treat Ocular Disease

November 20, 2021

LumiThera Acquires Diopsys, Provider of Light-Based Theranostic Approach to Treat Ocular Disease LumiThera announced its entry into a definitive merger agreement with Diopsys, a provider of modern visual electrophysiology medical devices that help eye care professionals analyze the entire visual pathway for visual and neuro-visual disorders. Under the terms of the agreement, which has been…

LumiThera announces acquisition of Diopsys

November 15, 2021

LumiThera announces acquisition of Diopsys NEW ORLEANS — LumiThera announced it has entered into a definitive merger agreement with Diopsys, according to a press release. In the agreement, Diopsys stockholders will receive stock in LumiThera, and Diopsys will become a wholly owned subsidiary of LumiThera. “As of this morning, we announced Diopsys and LumiThera are…

LumiThera, Inc. Announces Creation of a Light-based Theranostic Approach to Treat Ocular Disease with Acquisition of Diopsys, Inc.

November 12, 2021

LumiThera, Inc. Announces Creation of a Light-based Theranostic Approach to Treat Ocular Disease with Acquisition of Diopsys, Inc. SEATTLE, Nov. 11, 2021 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced its entry into a definitive merger agreement with Diopsys, Inc., a leader…

Mocca Shots Now Available at Walmart Stores Nationwide

August 25, 2022

Mocca Shots Now Available at Walmart Stores Nationwide POSTED ON AUGUST 17, 2022 MOCCA SHOTS 4-PACKS ARE NOW AVAILABLE NATIONWIDE AT 4,800+ WALMART LOCATIONS. Seattle Gummy Company (SGC) proudly announces that their groundbreaking Mocca Shots caffeine gummies are available nationwide at 4800+ Walmart stores and walmart.com. Each pack of Mocca Shots contains 200 mg of…

SGC Appearing on No Retreat: Business Bootcamp

March 12, 2022

SGC Appearing on No Retreat: Business Bootcamp Seattle Gummy Company Takes Their Business To The Next Level on CNBC’s New Reality TV Show Seattle Gummy Company is doing whatever it takes to step up their business game with the help of Spartan Founder, Joe De Sena. Seattle, WA: Seattle Gummy Company, the leaders in functional…

Dr. Marc Goldstein Joins Seattle Gummy Company’s Medical Advisory Board

February 19, 2022

Dr. Marc Goldstein Joins Seattle Gummy Company’s Medical Advisory Board Dr. Marc Goldstein has joined gummy medicine pioneer Seattle Gummy Company’s (SGC) medical advisory board, bringing his decades of award-winning medical experience to the table. SGC CEO, Dr. Connie Wan, says she is “thrilled to continue to expand our medical advisory board.” Dr. Goldstein is…

Seattle Gummy Company Announces Dr. Michael Jensen As Medical Advisor

December 16, 2021

Seattle Gummy Company Announces Dr. Michael Jensen As Medical Advisor Hailing from Mayo Clinic, Dr. Michael Jensen is joining the Seattle Gummy Company (SGC) as a medical advisor. Dr. Jenson, who currently holds the Thomas J. Watson, Jr. Professorship in Honor of Dr. Robert L. Frye at the Mayo Clinic Alix School of Medicine, received…

Invest in Seattle Gummy Company

October 20, 2021

Seattle Gummy Company is in the process of launching a Series B raise to accelerate our gummy medicine pipeline. As a part of the raise, we have carved out a portion as an opportunity for everyone who has believed in our mission and supported us over the last couple of years to invest in the…

Seattle Gummy Company Secures The First (IND) Gummy Drug Approval From FDA

October 15, 2020

SEATTLE, Oct. 15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312. Led by founder and CEO, Dr. Connie Wan, SGC…

Seattle Gummy Company voted as one of the most innovative companies at 2018 Silicon Valley Innovation and Entrepreneurship Startups Competition

September 30, 2018

By cwan | September 30th, 2018 SEATTLE, Washington – The 2018 Silicon Valley Innovation and Entrepreneurship Forum (SVIEF) has successfully closed its 2018 SVIEF conference on September 30th 2018 at Santa Clara Convention Center. Attracting over 10,000 attendees, SVIEF2018 conference was designed to be intense and informative two-day event with the theme of ” Converge…

Seattle Gummy Company won top prize recognized as the most innovative company at 2018 Xiamen-Silicon Valley Tech Startups Competition

September 29, 2018

By cwan | September 29th, 2018 SEATTLE, Washington – Xiamen is one of the earliest four special economic zones established in China. Its economic openness and average growth rate have long been ranked among the largest cities in China, and World Bank chose is as a “top investment environment city”. Open and diverse cultural heritage and unique…

East-West Summit Highlights Spokane’s Emergence As A Thriving Life Science Hub

June 21, 2023

East-West Summit Highlights Spokane’s Emergence As A Thriving Life Science Hub JUNE 20, 2023 Renowned for its picturesque landscapes, outdoor activities, and the famous Hoopfest, the Spokane area is on the brink of establishing itself as a leader in the life science industry. With the presence of two esteemed medical schools, the emergence of new…

Partnering For Success: Trends In Contract Medical Device Development And Manufacturing

March 10, 2023

Partnering For Success: Trends In Contract Medical Device Development And Manufacturing MARCH 9, 2023 The world of healthcare is constantly evolving, and the medical device industry is no exception. The 2023 U.S. Medtech Contract Manufacturing Report from Alira Health predicts a promising future for the medical device market, with a projected growth rate of…

GM Ogle Joins Product Creation Studio as New Executive Hire

February 25, 2023

GM Ogle Joins Product Creation Studio as New Executive Hire FEBRUARY 22, 2023 GM Ogle, ex-Microsoft executive and member of the original Surface Pro team, has joined the Seattle-based product design and development company as a hardware and user experience leader. Seattle, WA – Product Creation Studio, a leading product design and development…

Product Creation Studio Wins IDEA Design Award For The Brio Air Purifier

September 25, 2022

Product Creation Studio Wins IDEA Design Award For The Brio Air Purifier SEPTEMBER 16, 2022 Product Creation Studio was awarded the prestigious Bronze International Design Excellence Award (IDEA) at the 2022 International Design Conference for our work on the Brio Air Purifier system from Agentis Air. Brio’s innovative indoor air purification system creates filtered, clean…

DeviceConnect Highlights & Video: Novel Delivery Mechanisms For Modern Medicine

May 26, 2022

DeviceConnect Highlights & Video: Novel Delivery Mechanisms For Modern Medicine MAY 24, 2022 On May 10, Product Creation Studio and Life Science Washington hosted DeviceConnect to discuss the rapid evolution of modern medicine, spurred by incredible advancements in vaccine and drug delivery. Featuring panelists with expertise ranging from pharmaceutical therapeutics to biotechnology to…

April Events: Medical Device Design At MD&M And Innovation At LSINW

April 1, 2022

April Events: Medical Device Design At MD&M And Innovation At LSINW MARCH 30, 2022 Product Creation Studio is excited to participate in two (2) in-person events next month in the medical device design and life sciences space. These events will provide an opportunity for attendees to learn how to both de-risk and innovate within the…

Client News: Madorra CEO Holly Rockweiler Talks Design Thinking On Medsider Podcast

March 22, 2022

Client News: Madorra CEO Holly Rockweiler Talks Design Thinking On Medsider Podcast MARCH 21, 2022 We love to see our clients earn recognition for their innovative products. This month, Madorra CEO Holly Rockweiler talks about their home ultrasound product and how they harnessed the power of user-centered design to innovate. Why Design Thinking is Crucial…

Medical Device Design And Miniaturization: Scott Thielman’s Interview With MD+DI

March 16, 2022

Medical Device Design And Miniaturization: Scott Thielman’s Interview With MD+DI MARCH 15, 2022 MD+DI recently spoke with Product Creation Studio CTO, Scott Thielman, to learn about the opportunities for medical device miniaturization, in particular design innovations, prototyping, manufacturing, and more. Article excerpt: Such gains in cardiovascular devices are now inspiring new frontiers for miniaturization.…

Product Creation Studio Wins A Silver And Honorable Mention IDA Design Award

February 1, 2022

Product Creation Studio Wins A Silver And Honorable Mention IDA Design Award JANUARY 24, 2022 In partnership with our clients, glassybaby and Agentis Air, two of Product Creation Studio’s designs were recently named as award finalists for the 2021 IDA Design Awards! Evie Tealights for glassybaby was awarded the Silver Design Award in IDA’s Luminary/Special…

Congratulations To Client LumiThera, Seattle Business Magazine’s 2019 Leaders In Healthcare Award Winner!

March 15, 2019

March 14, 2019 Product Creation Studio is proud to congratulate our client, LumiThera, on their recent Leaders in Healthcare, Achievement in Medical Technology award from Seattle Business magazine. LumiThera is medical device company focused on treating people affected by ocular disorders and diseases including dry age-related macular degeneration. The company is developing the office-based Valeda™…

Soteria Seeks Advanced Development Partners for Consumer Lithium-ion Battery Fire Alarm System

October 20, 2023

Soteria Seeks Advanced Development Partners for Consumer Lithium-ion Battery Fire Alarm System 18 Oct, 2023 Lithium-ion battery fires in the home are on the rise, and home smoke alarms are not effective at detecting the emissions from a lithium-ion battery fire. Soteria has lifesaving, patent-pending technology for an alarm system that will detect…

Nanotech Energy, Soteria Battery Innovation Group, and Voltaplex Energy announce plans to commercialize safe, American-made battery packs for e-bikes

August 31, 2023

Nanotech Energy, Soteria Battery Innovation Group, and Voltaplex Energy announce plans to commercialize safe, American-made battery packs for e-bikes 30 Aug, 2023 Domestically produced non-flammable 18650s will be available in early 2024 GREENVILLE, S.C., Aug. 30, 2023 /PRNewswire/ — E-bike battery safety concerns could soon begin to fade after Nanotech Energy, Soteria Battery Innovation Group, and Voltaplex…

Battery industry experts convene to address lithium-ion battery fires and solutions

August 30, 2023

Battery industry experts convene to address lithium-ion battery fires and solutions 29 Aug, 2023 Soteria Battery Innovation Group and NAATBatt to host 2nd Annual LithiumSAFE Battery Safety Workshop GREENVILLE, S.C., Aug. 29, 2023 /PRNewswire/ — Soteria Battery Innovation Group and NAATBatt International announced they will host the second annual LithiumSAFE Battery Safety Workshop from October 17th – 19th, 2023, in Greenville, South…

E-bike Battery Safety Called into Question by Interim Project Results

June 29, 2023

E-bike Battery Safety Called into Question by Interim Project Results 28 Jun, 2023 In Soteria’s E-bike Battery Safety Project, 8 e-bike battery packs have been disassembled and over 1,000 e-bike riders have been polled. The interim results reveal the shocking truth about the industry, with only 1 OEM taking significant strides to improve battery pack…

Soteria Reorients Consortium to Wholistic Lithium-ion Battery Safety and Launches Content Platform to Support Shift

May 12, 2023

Soteria Reorients Consortium to Wholistic Lithium-ion Battery Safety and Launches Content Platform to Support Shift 11 May, 2023 Lithium-ion battery safety is an extremely pressing issue, which is why Soteria is reorienting its consortium to help address the industry-wide problem. To support this, Soteria has launched a new content platform to house and disseminate battery…

Soteria Battery Innovation Group acquires battery company, sets up new division

January 25, 2023

Soteria Battery Innovation Group acquires battery company, sets up new division Jan 18, 2023, 13:02 ET GREENVILLE, S.C., Jan. 18, 2023 /PRNewswire/ — Soteria Battery Innovation Group has acquired the assets of Voltaplex (www.voltaplex.com) which it will use to form the core of a battery material, cell and pack distribution division while expanding their international presence. …

DuPont Technology at the Forefront of Next-gen Lithium-ion Batteries

June 29, 2022

DuPont Technology at the Forefront of Next-gen Lithium-ion Batteries As electric vehicles become more prevalent, scientists and engineers are working on new battery designs to increase the range of these vehicles, while reducing the dependence on scarce metals such as copper and aluminum. Recently, DuPont Electronics & Industrial (E&I) partnered with Steinerfilm, which…

delfort and Soteria Sign Marketing License Agreement

January 1, 2022

delfort and Soteria Sign Marketing License Agreement December 17, 2021: delfort has decided to partner with Soteria Battery Innovation Group (BIG) Maintaining a long tradition of innovation, delfort has spent the last years developing cellulose and advanced fiber-based separators. The energy storage market is rapidly growing, and battery safety has always been a critical topic,…

SVOLT sources cell technology from Soteria

May 25, 2021

SVOLT sources cell technology from Soteria SVOLT, the battery cell manufacturer that emerged from the Chinese carmaker Great Wall, has announced new lithium-ion cells that will use safety technology from Soteria Battery Innovation Group (BIG) for the first time. The market launch of these cells is planned for the third quarter of 2021. …

Ahlstrom-Munksjö signs marketing license for fiber-based separator for lithium-ion batteries

May 1, 2021

No Comments

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE APRIL 28, 2021 at 15:00 EST Ahlstrom-Munksjö advances further into the energy storage market by signing a marketing license with Soteria Battery Innovation Group (BIG), allowing the company to proceed with the technical ramp-up to manufacture fiber-based separator solutions to the lithium-ion battery industry. The agreement is an important step in…

Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months

July 19, 2023

Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months Jul 18, 2023 Ottawa, Canada, July 18, 2023 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it has successfully…

Orion Biotechnology Presenting at the 2nd GPCR-Targeted Drug Discovery Summit in Boston

February 17, 2023

Orion Biotechnology Presenting at the 2nd GPCR-Targeted Drug Discovery Summit in Boston February 16, 2023 13:15 ET | Source: Orion Biotechnology Canada Ltd. Ottawa, Canada, Feb. 16, 2023 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that…

Orion Biotechnology Publishes White-paper Highlighting the Importance and Challenges in Unlocking “Undruggable” GPCRs

February 3, 2023

Orion Biotechnology Publishes White-paper Highlighting the Importance and Challenges in Unlocking “Undruggable” GPCRs February 02, 2023 10:07 ET | Source: Orion Biotechnology Canada Ltd. Ottawa, Canada, Feb. 02, 2023 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced…

Orion Biotechnology Shares In Vivo Efficacy Data on its Latest Best-in-Class Drug Candidate

December 2, 2022

Orion Biotechnology Shares In Vivo Efficacy Data on its Latest Best-in-Class Drug Candidate December 01, 2022 11:08 ET Ottawa, Canada, Dec. 01, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it has obtained…

Orion Biotechnology to Attend the LSX Investival Showcase and Jefferies Healthcare Conference

November 11, 2022

Orion Biotechnology to Attend the LSX Investival Showcase and Jefferies Healthcare Conference November 10, 2022 09:03 ET Ottawa, Ontario, Canada, Nov. 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it will be participating…

Orion Biotechnology to present at 2022 Dr. GPCR Summit Conference

October 12, 2022

Orion Biotechnology to present at 2022 Dr. GPCR Summit Conference October 11, 2022 09:03 ET | Source: Orion Biotechnology Canada Ltd. Ottawa, Canada, Oct. 11, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a drug discovery and development company unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs), today announced that it will be…

Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable Al-Driven Drug Discovery Against Undrugged GPCR Target

July 13, 2022

Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable Al-Driven Drug Discovery Against Undrugged GPCR Target Ottawa, Canada & Pittsburgh, USA, July 12, 2022 (GLOBE NEWSWIRE) -Orion Biotechnology Canada Ltd, a drug discovery company targeting previously undruggable G Protein-Coupled Receptors (GPCRs), and Peptilogics, a biotech company engineering peptide therapeutics by combining computation and…

ORION BIOTECHNOLOGY ADDS GPCR EXPERT TO ITS SCIENTIFIC ADVISORY BOARD

July 6, 2022

No Comments

ORION BIOTECHNOLOGY ADDS GPCR EXPERT TO ITS SCIENTIFIC ADVISORY BOARD Ottawa, Canada, July 05, 2022 {GLOBE NEWSWIRE} — Orion Biotechnology Canada Ltd, a drug discovery and development company targeting previously-undruggable G Protein-Coupled Receptors {GPCRs}, today announced that Dr. Antal Rot, a world-renowned expert in the role of chemokines in inflammation, has joined Orion’s scientific…

ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS LATEST BEST-IN-CLASS GPCR DRUG CANDIDATE

May 12, 2022

ORION BIOTECHNOLOGY PRESENTING NEW DATA ON ITS LATEST BEST-IN-CLASS GPCR DRUG CANDIDATE May 10, 2022 13:03 ET | Source: Orion Biotechnology Canada Ltd. Ottawa, Canada, May 10, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs), today announced that it will…

ORION BIOTECHNOLOGY PRESENTING NEW DATA AT THE GPCR DRUG DISCOVERY SUMMIT

March 22, 2022

ORION BIOTECHNOLOGY PRESENTING NEW DATA AT THE GPCR DRUG DISCOVERY SUMMIT Ottawa, Ontario, Canada, March 22, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd, a clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs), today announced that it will be presenting important new data at the GPCRs-Targeted Drug Discovery Summit, taking place…

KitoTech Medical Inc. Announces Publication of Clinical Results of Laceration Repair Study in The Emergency Medical Journal

August 5, 2023

KitoTech Medical Inc. Announces Publication of Clinical Results of Laceration Repair Study in The Emergency Medical Journal 02 Aug, 2023 SEATTLE (PRWEB) August 02, 2023 — In the clinical study, lacerations in 31 patients were closed with microMend PRO. Ninety percent or more of healthcare providers reported good to excellent outcomes in all measured…

KitoTech’s microMend® Laceration Repair Kit Under Walgreens Private Label Brand Named Best New Store Brand Medical Product in 2022

August 26, 2022

KitoTech’s microMend® Laceration Repair Kit Under Walgreens Private Label Brand Named Best New Store Brand Medical Product in 2022 Store Brands Magazine selected Walgreens Wound Closure Laceration Repair Kit, a private label brand of the microMend® laceration repair kit, for its Editor’s Pick Gold Star Award as Best New Store Brand Medical Product this…

KitoTech Medical Signs Agreement with Corza Medical to Market microMend PRO Wound Closure Devices in U.S.

April 12, 2022

KitoTech Medical Signs Agreement with Corza Medical to Market microMend® PRO Wound Closure Devices in U.S. SEATTLE (PRWEB) APRIL 12, 2022 KitoTech Medical, Inc. has entered a distribution agreement with Corza Medical, Inc. to sell the microMend® family of wound closure products in the medical and surgical markets in the United States. KitoTech Medical has…

KitoTech Medical Launches microMend® Skin Closure Variety Pack for Consumer Market

November 19, 2021

KitoTech Medical Launches microMend® Skin Closure Variety Pack for Consumer Market SEATTLE (PRWEB) NOVEMBER 17, 2021 KitoTech Medical, a medical device company, announces the addition of the microMend® Variety Pack to its growing line of consumer skin closure products. The new product contains three different microMend Skin Closure device sizes, all designed for easy application…

KitoTech Medical Exhibits at the American College of Emergency Physicians (ACEP) Scientific Assembly 2021

October 29, 2021

KitoTech Medical Exhibits at the American College of Emergency Physicians (ACEP) Scientific Assembly 2021 SEATTLE (PRWEB) OCTOBER 28, 2021 KitoTech Medical, manufacturer of microMend® Skin Closure devices, announces that it exhibited at the recent American College of Emergency Physicians (ACEP) Scientific Assembly 2021 in Boston, MA. Hundreds of physicians and other front-line emergency medical personnel…

KitoTech Medical Announces Dr. John Canady Has Joined as Its Chairman of Scientific Advisory Board

October 12, 2021

KitoTech Medical Announces Dr. John Canady Has Joined as Its Chairman of Scientific Advisory Board SEATTLE (PRWEB) OCTOBER 11, 2021 KitoTech Medical, manufacturer of microMend® Wound Closure Products, announces today that John Canady, MD, DSc, has joined KitoTech as Chairman of its Scientific Advisory Board. Dr. Canady is a leading plastic surgeon who previously held…

KitoTech Medical Announces David Krall Has Joined as Its Vice President of Sales and Marketing

October 7, 2021

KitoTech Medical Announces David Krall Has Joined as Its Vice President of Sales and Marketing SEATTLE (PRWEB) OCTOBER 07, 2021 KitoTech Medical, manufacturer of microMend® Wound Closure Products, announces today that David Krall, an experienced J&J sales and marketing executive, has joined KitoTech as its Vice President of Sales and Marketing. David brings 28 years…

KitoTech Medical Introduces microMend® UMBILICAL Device for Closing the Umbilical Port Site in Laparoscopic and Robotic Surgeries

July 30, 2021

KitoTech Medical Introduces microMend® UMBILICAL Device for Closing the Umbilical Port Site in Laparoscopic and Robotic Surgeries SEATTLE, WASH. (PRWEB) JULY 28, 2021 KitoTech Medical, manufacturer of microMend® wound closure devices, announces the launch of microMend UMBILICAL, the newest addition to our growing family of wound closure products. The product was specifically designed to close…

KitoTech Medical Introduces New microMend® Wound Closure Product for the Consumer Market

March 22, 2021

KitoTech Medical Introduces New microMend® Wound Closure Product for the Consumer Market KitoTech adds new microMend® Combo Pack to growing line of consumer products and expands the use of microMend to close smaller lacerations and serious cuts on fingers and discrete areas of the face. SEATTLE (PRWEB) MARCH 22, 2021 KitoTech Medical, a medical device…

KitoTech Medical Announces New U.S. Patent Granted on Its microMend® Wound Closure Products

March 18, 2021

KitoTech Medical Announces New U.S. Patent Granted on Its microMend® Wound Closure Products KitoTech announces today that its second U.S. patent has been issued which extends IP coverage for its innovative microMend wound closure technology. SEATTLE (PRWEB) MARCH 18, 2021 KitoTech Medical, a Seattle-based medical device company, announced today that the U.S. Patent and Trademark…

SWIR Vision Systems Announces Acuros GO 6 MP Handheld SWIR Camera

January 20, 2024

SWIR Vision Systems Announces Acuros GO 6 MP Handheld SWIR Camera January 18, 2024 Empowering Mobile SWIR Imaging with Cutting-Edge CQD® Sensor Technology DURHAM, NORTH CAROLINA — SWIR Vision Systems, a leader in short-wavelength infrared (SWIR) imaging technology, proudly introduces the Acuros® GO 6 MP SWIR camera, a groundbreaking portable, handheld mirrorless camera…

SWIR Vision Systems Secures Direct to Phase II SBIR Award for Low-Cost SWIR ALPD Technology

January 6, 2024

SWIR Vision Systems Secures Direct to Phase II SBIR Award for Low-Cost SWIR ALPD Technology January 5, 2024 Durham, NC – SWIR Vision Systems, a leader in shortwave infrared (SWIR) imaging technology, proudly announces its achievement in receiving a direct to Phase II Small Business Innovation Research (SBIR) award. This prestigious grant underscores the…

SWIR Vision Systems Unveils 6.3 MP and 4.2 MP Short Wave Infrared Cameras

November 30, 2023

SWIR Vision Systems Unveils 6.3 MP and 4.2 MP Short Wave Infrared Cameras The company’s Acuros 6 CQD SWIR Camera establishes new industry benchmark for SWIR camera resolution DURHAM, NC, November 29, 2023 /24-7PressRelease/ — SWIR Vision Systems, a leader in short-wavelength infrared (SWIR) imaging technology, announces the release of a new generation of SWIR Cameras,…

SWIR Vision Systems to release industry-leading 6 MP SWIR sensors for defense, scientific, automotive, and industrial vision markets

October 31, 2023

SWIR Vision Systems to release industry-leading 6 MP SWIR sensors for defense, scientific, automotive, and industrial vision markets October 31, 2023 The company’s latest innovation, the Acuros® 6, leverages its pioneering CQD® Quantum Dot image sensor technology, further contributing to the availability of very high resolution and broad-band sensors for a diversity of applications. …

SWIR Vision Announces New Products for Machine Vision Imaging and New Investment Partner

October 25, 2022

SWIR Vision Announces New Products for Machine Vision Imaging and New Investment Partner Infrared Imaging Solution for Li:Ion Battery Inspection to improve battery capacity DURHAM, NC, October 24, 2022 SWIR Vision Systems Inc. today announced breakthrough capability for its quantum dot based short wavelength infrared (SWIR) machine vision camera inspection product, and the Company announces…

SWIR Vision Announces Capability for Consumer and Automotive Sensing Systems

April 10, 2022

SWIR Vision Announces Capability for Consumer and Automotive Sensing Systems Solution for longer range, sunlight compatible, AR/VR and mobile device 3D depth sensing RESEARCH TRIANGLE PARK, NC, April 4th, 2022 – SWIR Vision Systems Inc. today announced breakthrough capability for its quantum dot based short wavelength infrared (SWIR) sensor technology. The company’s latest advancements, reported…

SPIE and Photonics Media announce finalists for 2022 Prism Awards

December 15, 2021

SPIE and Photonics Media announce finalists for 2022 Prism Awards The annual awards celebrate the best of photonics innovation in areas such as industrial lasers, biomedical devices, augmented and virtual reality, and quantum 15 December 2021 BELLINGHAM, Washington, USA — Industry giants and emerging challengers will be honored at the Prism Awards in a ceremony…

SWIR Vision Systems Inc. raises $5 million to expand its infrared imaging business

October 25, 2021

SWIR Vision Systems Inc. raises $5 million to expand its infrared imaging business North-Carolina based company is building next generation, high resolution infrared sensor solutions, with ground-breaking quantum dot-based sensor technology. DURHAM, N.C., October 19, 2021 SWIR Vision Systems Inc., a company pioneering the next generation of image sensor solutions for industrial automation, autonomous vehicles…

SWIR Vision Systems Introduces First Commercial Full-HD eSWIR Cameras

August 28, 2020

SWIR Vision Systems Introduces First Commercial Full-HD eSWIR Cameras DURHAM, NC, August 14, 2020 /24-7PressRelease/ — SWIR Vision Systems Inc. today announced the commercial launch, production, and sales of the AcurosTM high definition, extended short-wave infrared (eSWIR) cameras. This new class of SWIR band cameras, featuring the company’s CQDTM Quantum Dot sensor technology, will compete…

RTI International Makes Follow-On Investment in SWIR Vision Systems

January 28, 2020

RTI International Makes Follow-On Investment in SWIR Vision Systems January 07, 2020 SWIR Vision Systems® is an infrared sensor technology and spin-out venture company from RTI International RESEARCH TRIANGLE PARK, N.C. — RTI International, a nonprofit research institute, today announced its participation in a multi-party financing round for SWIR Vision Systems Inc., a technology start-up…

Edmund Optics Highlights Everix Filters

October 26, 2022